Psyence Biomedical (PBMWW) Stock Price, News & Analysis

Company Overview

Psyence Biomedical (NASDAQ:PBMWW) is a clinical‐stage biotechnology company focused on developing allogeneic cell therapies for the treatment of chronic wounds. The company’s platform employs mesenchymal‐like cells designed to modulate inflammation, promote angiogenesis and accelerate tissue repair. Psyence Biomedical aims to address significant unmet needs in conditions such as diabetic foot ulcers and venous leg ulcers, where existing therapies often fall short.

The company’s lead product candidate, PBMB001, is an off‐the‐shelf, cryopreserved cell therapy intended for topical application to nonhealing wounds. Preclinical studies have shown that PBMB001 can enhance granulation tissue formation and speed wound closure, supporting its advancement into human clinical trials. Psyence Biomedical operates a GMP‐compliant manufacturing facility to produce clinical‐grade material and is scaling its processes to meet anticipated demand as programs progress.

Headquartered in Toronto, Psyence Biomedical conducts its research and development activities in collaboration with clinical sites and academic partners across North America. The management team brings together expertise in cell therapy development, regulatory affairs and commercial strategy. As the company advances its pipeline, it continues to explore additional indications and strategic partnerships to broaden the application of its regenerative medicine platform.

Key Stats

• Today's Range: $0.03 to $0.04
• 50-Day Range: $0.02 to $0.04
• 52-Week Range: $0.00 to $0.05
• Volume: 123,823 shs
• Average Volume: 55,124 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PBMWW Stock Analysis - Frequently Asked Questions

How have PBMWW shares performed this year?

Psyence Biomedical's stock was trading at $0.0144 at the start of the year. Since then, PBMWW shares have increased by 109.0% and is now trading at $0.0301.

How do I buy shares of Psyence Biomedical?

Shares of PBMWW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Manufacturing
• Industry: Pharmaceutical Preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:PBMWW
• CIK: 1985062
• Web: N/A
• Phone: 27744604171
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: N/A
• Beta: N/A